Pharma IQ Glossary: Co-Crystals
Co-Crystals are defined as a technology used to enhance solubility, stability and the IP position with respect to the development of active pharmaceutical ingredients (APIs). Exploring the co-crystallization potential around an API increases the intellectual property protection over a particular drug product; thus, reducing the risk of costly litigation and market erosion.
Working Towards Achieving True Co-Crystal Solubility
July 10 by Helen WinsorProf. Nair Rodriguez-Hornedo of the University of Michigan, discusses the latest successful strategies in making co-crystals, providing firsthand examples from the University's Department of Pharmaceu...
Be Prepared for Scale Up of Co-crystal Production
July 06 by Vaibhav SihorkarDr. Vaibhav Sihorkar, Head of Pharmaceutical Development at Aurigene Discovery Technologies in India, gave Pharma IQ his insights on existing challenges to co-crystal commercialisation. Wha...
